Strike Pharma
Strike Pharma develops proprietary technology for targeted nanoparticle delivery to enable the development of in vivo CAR therapies.
Strike Pharma is a biotech company, founded in 2020. It has raised $6.0M across 2 rounds, most recently a $4.8M Series A in February 2022.
- Founded
- 2020
- Website
- strikepharma.com
- Total Funding
- $6.0M
- Last Round
- $4.8M Series AFeb 2022
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 2 investors for this company. to use credits for reveals, or explore the API.
About
Strike Pharma develops proprietary technology for targeted nanoparticle delivery to enable the development of in vivo CAR therapies.
Funding History
Feb 2022
1 more funding event
- Seed2021
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Companies in related industries

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/strike-pharma"><img src="https://indexed.vc/api/badge/company/strike-pharma" alt="Strike Pharma on Indexed.vc" width="260" height="76" /></a>
